Make an enquiry
Refer a patient
Patient Portal
HCP Logout

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Make an enquiry
Refer a patient

We noticed you are on our AU page. Want to switch regions? Choose from the options:

UK
ES
Find a centre
Find a doctor
2024-08-28T05:41:59.876Z

AAA603-NeoB-Breast

AAA603-NeoB-Breast
Breast cancer

A Phase I/II open label multi-centre trial of 177Lu Lu-Neo-B in combination with capecitabine in adult patients with gastrin releasing peptide receptor positive oestrogen receptor positive human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine therapy in combination with CDK 4/6 inhibitor

A Phase I/II open label multi-centre trial of 177Lu Lu-Neo-B in combination with capecitabine in adult patients with gastrin releasing peptide receptor positive oestrogen receptor positive human epidermal growth receptor-2 negative metastatic breast cancer after progression on previous endocrine therapy in combination with CDK 4/6 inhibitor

Trial overview

Clinical Area

Theranostics

Disease / Condition

Breast Cancer

Study Phase

I

Trial Identifiers

NCT06247995

 

https://clinicaltrials.gov/study/NCT06247995 

GenesisCare Location(s)

GenesisCare Cabrini

GenesisCare Cabrini :::
Principal Investigator(s)

Dr Dinesh Sivaratnam

 

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.